227 related articles for article (PubMed ID: 24433238)
1. Rebalanced hemostasis in patients with idiopathic thrombocytopenic purpura.
Kim WH; Park JB; Jung CW; Kim GS
Platelets; 2015; 26(1):38-42. PubMed ID: 24433238
[TBL] [Abstract][Full Text] [Related]
2. Differential roles of fibrinogen and von Willebrand factor on clot formation and platelet adhesion in reconstituted and immune thrombocytopenia.
Misgav M; Shenkman B; Budnik I; Einav Y; Martinowitz U
Anesth Analg; 2011 May; 112(5):1034-40. PubMed ID: 21474661
[TBL] [Abstract][Full Text] [Related]
3. Can thrombelastography be a new tool to assess bleeding risk in patients with idiopathic thrombocytopenic purpura?
Gunduz E; Akay OM; Bal C; Gulbas Z
Platelets; 2011; 22(7):516-20. PubMed ID: 21557684
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura.
Julia A; Kovaleva L; Loria S; Alberca I; Hernandez F; Sandoval V; Sierra J; Vidaller A; Ayguasanosa J; Carretero M
Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289
[TBL] [Abstract][Full Text] [Related]
5. Effects of increased von Willebrand factor levels on primary hemostasis in thrombocytopenic patients with liver cirrhosis.
Wannhoff A; Müller OJ; Friedrich K; Rupp C; Klöters-Plachky P; Leopold Y; Brune M; Senner M; Weiss KH; Stremmel W; Schemmer P; Katus HA; Gotthardt DN
PLoS One; 2014; 9(11):e112583. PubMed ID: 25397410
[TBL] [Abstract][Full Text] [Related]
6. [Acquired von Willebrand syndrome in a patient with immune thrombocytopenic purpura].
Ihara A; Suzuki N; Matsushita T; Ichinose A
Rinsho Ketsueki; 2015 Jul; 56(7):901-4. PubMed ID: 26256928
[TBL] [Abstract][Full Text] [Related]
7. Altered hemostasis in migraineurs studied with a dynamic flow system.
Tietjen GE; Al-Qasmi MM; Athanas K; Utley C; Herial NA
Thromb Res; 2007; 119(2):217-22. PubMed ID: 16504253
[TBL] [Abstract][Full Text] [Related]
8. An experimental model for testing von Willebrand factor function: successful SLA-matched crossed bone marrow transplantations between normal and von Willebrand pigs.
Roussi J; Samama M; Vaiman M; Nichols T; Pignaud G; Bonneau M; Sigman J; de Castro H; Griggs T; Drouet L
Exp Hematol; 1996 Apr; 24(5):585-91. PubMed ID: 8605962
[TBL] [Abstract][Full Text] [Related]
9. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of primary haemostasis in people with neurofibromatosis type 1.
Favaloro EJ; Zafer M; Nair SC; Hertzberg M; North K
Clin Lab Haematol; 2004 Oct; 26(5):341-5. PubMed ID: 15485464
[TBL] [Abstract][Full Text] [Related]
11. Role of plasma and platelet von Willebrand factor in arterial thrombogenesis and hemostasis in the pig.
André P; Brouland JP; Roussi J; Bonneau M; Pignaud G; Bal dit Sollier C; Hainaud P; Vaiman M; Drouet L
Exp Hematol; 1998 Jul; 26(7):620-6. PubMed ID: 9657137
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of hemostatic balance in blood from patients with polycythemia vera by means of thromboelastography: the effect of isovolemic erythrocytapheresis.
Rusak T; Ciborowski M; Uchimiak-Owieczko A; Piszcz J; Radziwon P; Tomasiak M
Platelets; 2012; 23(6):455-62. PubMed ID: 22098131
[TBL] [Abstract][Full Text] [Related]
13. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
14. Adult primary and secondary immune thrombocytopenic purpura: a comparative analysis of characteristics and clinical course.
Ayesh MH; Alawneh K; Khassawneh B; Khader Y; Kasasbeh A
Clin Appl Thromb Hemost; 2013 Jun; 19(3):327-30. PubMed ID: 22275396
[TBL] [Abstract][Full Text] [Related]
15. Extracorporeal membrane oxygenation induces short-term loss of high-molecular-weight von Willebrand factor multimers.
Tauber H; Ott H; Streif W; Weigel G; Loacker L; Fritz J; Heinz A; Velik-Salchner C
Anesth Analg; 2015 Apr; 120(4):730-6. PubMed ID: 25565317
[TBL] [Abstract][Full Text] [Related]
16. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device.
Meyer AL; Malehsa D; Bara C; Budde U; Slaughter MS; Haverich A; Strueber M
Circ Heart Fail; 2010 Nov; 3(6):675-81. PubMed ID: 20739614
[TBL] [Abstract][Full Text] [Related]
17. The anti-von Willebrand factor aptamer ARC1779 increases von Willebrand factor levels and platelet counts in patients with type 2B von Willebrand disease.
Jilma-Stohlawetz P; Knöbl P; Gilbert JC; Jilma B
Thromb Haemost; 2012 Aug; 108(2):284-90. PubMed ID: 22740102
[TBL] [Abstract][Full Text] [Related]
18. [Multimeric composition of von Willebrand factor in thrombotic thrombocytopenic purpura. Japanese TTP Study Group].
Tatewaki W
Nihon Rinsho; 1993 Jan; 51(1):146-50. PubMed ID: 8433508
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients.
Ames PR; Pyke S; Iannaccone L; Brancaccio V
Thromb Haemost; 1995 May; 73(5):768-73. PubMed ID: 7482401
[TBL] [Abstract][Full Text] [Related]
20. Initial laboratory findings useful for predicting the diagnosis of idiopathic thrombocytopenic purpura.
Kuwana M; Okazaki Y; Satoh T; Asahi A; Kajihara M; Ikeda Y
Am J Med; 2005 Sep; 118(9):1026-33. PubMed ID: 16164890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]